Home
About Us
Company Profile
Development History
Corporate Culture
Production Quality
Products&Services
Product Center
Research and Development
CDMO
Business Layout
Investor
Events
Press Releases
Contact Us
Chinese
English
日本語
Product Catalog
→ Small molecule compound
→ Commercialized Active Pharmaceutical Ingredient
→ Active pharmaceutical ingredients under development
→ Polypeptide compounds
Commercialized Active Pharmaceutical Ingredient
Product Name
CAS Number
Specification
TP
DMF
Status
Tasimelteon
609799-22-6
In-house
√
Ticagrelor
274693-27-5
EP, In-house
Tofacitinib Citrate
540737-29-9
Trametinib dimethyl sulfoxide
1187431-43-1
Q4 2025
Travoprost
157283-68-6
USP, In-house